Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 14.05% vs 23.11% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -100.00% vs 18.88% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of DHG Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -31.24% vs 52.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 65.43% vs -8.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 5.42% vs 33.49% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 14.05% vs 23.11% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






